ConductScience.org, home

Paper3947546

Primary thrombocythaemia treated with busulphan.

Van de Pette JE and 5 others. Br J Haematol, 1986. Cited by 77 papers, by iCite.

Cite this record

ConductScience Library. Primary thrombocythaemia treated with busulphan. Papers, record 3947546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3947546

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Primary thrombocythaemia treated with busulphan.
PubMed
Journal
Br J Haematol
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
77
iCite
Relative citation ratio, by iCite
3.76
iCite
Revised in PubMed
2019-07-04
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van de Pette JEJ E
2Prochazka AVA V
3Pearson TCT C
4Singh AKA K
5Dickson ERE R
6Wetherley-Mein GG

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BusulfanMajor topic
Thrombocythemia, EssentialMajor topic
Adult
Aged
Blood Cell Count
Bone Marrow
Female
Humans
Male
Middle Aged
Philadelphia Chromosome
Prognosis
Time Factors

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.

PMIDTitleJournalYearIn PapersSource
17611572Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia.Leukemia2007https://conductscience.org/library/papers/17611572PubMed
12430943What is the standard treatment in essential thrombocythemia.Int J Hematol2002https://conductscience.org/library/papers/12430943PubMed
12357360Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea.Leukemia2002https://conductscience.org/library/papers/12357360PubMed
10984199Polycythaemia vera and essential thrombocythaemia in the elderly.Drugs Aging2000https://conductscience.org/library/papers/10984199PubMed
10523796The role of busulfan in bone marrow transplantation.Med Oncol1999https://conductscience.org/library/papers/10523796PubMed
8347730Primary thrombocythemia: diagnosis, clinical manifestations and management.Ann Hematol1993https://conductscience.org/library/papers/8347730PubMed
8167182Familial essential thrombocythemia: clinical characteristics of 11 cases in one family.Ann Hematol1994https://conductscience.org/library/papers/8167182PubMed
2105111Recombinant interferon-alpha, but not interferon-gamma is effective therapy for essential thrombocythemia.Blut1990https://conductscience.org/library/papers/2105111PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3947546

GET https://conductscience.org/api/papers/v1/3947546/authors